BARCELONA—A radiotherapy dose of more than 54 Gy improved survival in children with localized cerebral ependymoma in a large multicenter study from France that looked at the role of age, grade and dose on outcome in 177 patients over a period of 13 years. Oncology Times reporter Sarah Maxwell discussed the findings—presented at the 3rd ESTRO Forum—with lead study author Anne Ducassou MD, from Institut Claudius Regaud in Toulouse, France.
You may also like...
Oncology Times Broadcast News with the Audio Journal of Oncology 11 Nov, 2008
Two New Second-Line Options For Patients With Advanced or Metastatic Non-Small Cell Lung Cancer 16 Nov, 2007
Androgen blockade: 18 as good as 36 months in radiotherapy-treated prostate cancer 24 Mar, 2013
Normal stem cells are not depleted in acute myeloid leukaemia and could be targeted therapeutically 9 Aug, 2013
- Previous story Boosting Radiotherapy Dose Improved Survival in Children with Ependymoma
- Next story ‘Rescanning’ Optimizes Pencil Beam Proton Delivery to Moving Lung Tumor
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014
- First enterovirus 71 vaccines effective against hand, foot and mouth diseaseFebruary 28, 2014